English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

It is estimated that approximately 1 billion individuals worldwide have hypertension, and more than 7 million deaths per year may be attributable to hypertension-induced complications and organ damage (1). The mechanisms underlying hypertension are complex and incompletely understood. To better control hypertension-induced end-organ damage, it is important to investigate new and effective targets for therapeutic intervention. Besides blood pressure level itself, recent studies have demonstrated that the spontaneous variation in blood pressure, called blood pressure variability (BPV), is another key determinant of hypertensive end-organ damage. Clinical trials have demonstrated that, for nearly any level of 24-h mean arterial blood pressure, hypertensive subjects with low 24-h BPV had a significantly lower prevalence and severity of organ damage than those with high BPV (2). Furthermore, the cardiovascular complications of hypertension may in fact depend on the degree of 24-h BPV (3). Tatasciore et al. showed that awake systolic BPV, via non-invasive ambulatory blood pressure monitoring, correlates with subclinical target-organ damage that is independent of mean blood pressure level in hypertensive subjects (4). In contrast, ambulatory blood pressure levels and BPV are closely associated with carotid artery alteration, as found in the Ohasama study, suggesting that these parameters are independent risk

Blood Pressure Variability Reduction and Organ Protection in Hypertension Treatment